Enseval Putera Megatrading Tbk PTEPMT:JKT

2,755
0.00 / 0.00%
0
26.53%
0.5591
Close in IDRToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Jan 16 2015 07:20 GMT.

About the company

16.95tn529.15bn19895.64k
Revenue in IDR (TTM)Net income in IDRIncorporatedEmployees
IndustryPharmaceuticals & BiotechnologyLocation
Enseval Putera Megatrading Tbk PT
Jl. Pulo Lentut No. 10
Kawasan Industri Pulogadung
JAKARTA TIMUR13920
Indonesia
IDN
Phone+62 214600200Fax+62 214609049Websitehttp://www.enseval.com
PT Enseval Putera Megatrading Tbk is an Indonesia-based company primarily engaged in distributing and trading pharmaceutical and consumer products. Its business is classified into three operating segments: pharmaceutical products, consumer products and others. The pharmaceutical products segment includes the distribution of prescription drugs and over-the-counter (OTC) drugs, while the consumer products segment comprises the distribution of nutritional products and other consumer products. Its others segment includes the distribution of medical equipment, veterinary products and raw materials for pharmaceutical industry as well as the provision of health care services. Its subsidiaries include PT Tri Sapta Jaya, which distributes pharmaceutical and health care products; PT Millenia Dharma Insani, which operates clinics under the brand name of Mitrasarana, and PT Enseval Medika Prima, which distributes medical equipment.

Mergers & acquisitions

There are no recent mergers or acquisitions for Enseval Putera Megatrading Tbk PT.
Data delayed at least 15 minutes, as of Jan 16 2015 07:20 GMT.

Peer analysis

Company Revenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings
(TTM)
Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excluding
extraordinary items (TTM)
EPS (including
extraordinary items) (TTM)
Revenue per
share (TTM)
Book value per
share (MRQ)
Asset turnover
(TTM)
Inventory turnover
(TTM)
Receivables turnover
(TTM)
Revenues per
employee (TTM)
Return on
average
assets
(TTM)
Return on
average
assets
(5 yr average)
Return on
investment
(TTM)
Return on
investment
(5 yr average)
Gross margin (TTM)Gross margin (5 yr average)Net profit margin (TTM)Net Profit margin (5 Yr Average)Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio (5 yr average)Revenue
(Year-over-year change%)
Revenue
(5 yr growth rate)
Net income
(Year-over-year change%)
Net income
(5 Yr growth rate)
Capital
expenditure
(5 Yr growth rate)
Dividend
(5 yr growth rate)
Sichuan Di Kang Sci&Tech Pharm. Ind. Co.
790.08bn45.83bn7.02tn1.01k153.135.87--8.880.05230.05230.90171.360.58022.996.35391,5583.364.263.694.2660.3351.235.796.735.27--0.06780.003.279.625.0917.2717.83--
Zhejiang Zhenyuan Co.,Ltd.
4.14tn107.32bn7.09tn1.65k66.052.92--1.710.16090.16096.213.641.196.234.691,260,0803.205.404.685.4014.9913.102.702.281.58--0.07369.3811.3612.6435.1739.4174.27--
Unisplendour Guhan Group Corporation Ltd
346.86bn-327.57bn7.09tn1.86k--13.10--20.45-0.7349-0.73490.77821.210.28741.544.1993,385.62-27.1450.2554-45.18210.255450.8352.68-94.43880.27610.8562--0.15721,409.54-29.5581.59-219.508--1.44--
Hunan Fangsheng Pharmaceutical Co Ltd
829.93bn167.94bn7.70tn70634.406.8873.369.281.031.035.095.14----------------44.50--21.25--2.89--0.00--20.45--11.07------
Lanzhou Foci Pharmaceutical Co Ltd
765.91bn68.82bn7.77tn1.29k97.585.34--10.140.22440.22442.474.100.4042.103.19296,5643.637.394.187.3920.6434.668.9913.635.75--0.03644.729.455.890.79147.2068.12--
Chengdu Huasun Group Inc Ltd
1.15tn86.76bn7.85tn99690.496.75--6.830.11290.11291.501.510.59024.101.88578,4414.454.927.494.9242.0033.537.554.521.1515.280.239235.4513.3112.6148.6857.84-6.8115--
Shanxi Zhendong Pharmaceutical
3.34tn112.52bn7.90tn3.35k70.242.02--2.370.19580.19585.816.790.59533.433.42499,4901.546.002.136.0050.7155.042.597.381.313.600.192818.1119.5729.18-19.08654.5051.65--
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.
1.34tn188.88bn7.97tn1.98k41.992.44--5.970.24430.24431.724.200.34292.302.00338,4434.9711.345.8111.3459.5961.4514.4923.645.07--0.015837.1015.0127.495.4728.5366.51--
Center Laboratories, Inc.
352.39bn15.97bn7.55tn322420.184.25158.0121.420.21610.21614.7821.350.1295.187.47--0.75822.261.282.2639.6740.165.887.294.78--0.1030.003.9515.27-43.75722.69-0.4254--
Shilpa Medicare Ltd
1.25tn162.23bn7.34tn--45.857.1235.455.8820.4220.28156.77131.530.84473.439.76--10.8916.8714.0216.8743.6941.4312.9014.081.4027.620.24684.9653.8827.9859.84--14.6024.57
JCR Pharmaceuticals Co Ltd
1.74tn139.33bn7.63tn47254.062.8327.554.3841.2541.25515.89787.450.49461.103.7134,993,1303.953.984.893.9863.3864.077.996.841.68--0.103743.0511.395.3977.3919.1435.726.96
Humedix Co Ltd
327.01bn79.83bn6.90tn6668.7918.1973.1921.111,373.711,373.715,364.15,229.48----------------48.40--24.42--6.5040.100.0882--101.16--1,723.42------
Bukwang Pharmaceutical Co., Ltd.
1.61tn265.66bn7.70tn60225.093.0922.684.77779.18779.184,778.456,329.850.60892.033.61257,714,50010.02--10.69--56.62--16.45--8.11--0.00---11.3406--18.29------
Kimia Farma (Persero) Tbk PT
4.61tn236.93bn7.28tn5.46k30.714.2826.431.5842.6642.66830.01305.801.824.616.69864,566,7009.4212.3113.9112.3129.7429.535.184.511.2239.410.153918.2616.449.964.5931.1023.7727.92
Enseval Putera Megatrading Tbk PT
16.95tn529.15bn7.46tn5.64k14.102.2011.670.4403195.36195.366,256.491,252.692.977.318.683,844,507,0009.2716.7016.6416.7011.3911.363.123.121.13--0.0434--16.8316.1415.2911.7126.13--
Data as of Jan 26 2015. Currency figures normalised to Enseval Putera Megatrading Tbk PT's reporting currency: Indonesian Rupiah IDR.
Data delayed at least 20 minutes, as of Jan 26 2015 17:32 GMT.

Institutional shareholders

There are no institutional shareholders for Enseval Putera Megatrading Tbk PT.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.